GlycoMantra, Inc.

Quick Facts

Location: Tech South

Program: Tech South Incubator

Industry: Life Sciences / Bio Technology

Sub-Industry: Medical Therapeutics


GlycoMantra’s technology expertise is in glycobiology research leading to the development of carbohydrate-based therapeutics for treatment of advanced prostate cancer. The Company’s carbohydrate-based therapeutic drug, “GM101,” is expected to prevent cancer progression and metastasis in many cancers, particularly prostate adenocarcinoma.

Scroll to Top